CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹380 Cr | ₹21 Cr | ₹-55 Cr | ₹-109 Cr | ₹-146 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CIPLA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹380 Cr |
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹-55 Cr |
| Mar2023 | ₹-109 Cr |
| Mar2022 | ₹-146 Cr |
How is Net Cash Inflow / Outflow of CIPLA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹380 Cr | 1,706.37 | |
| Mar2025 | ₹21 Cr | Positive | |
| Mar2024 | ₹-55 Cr | Negative | |
| Mar2023 | ₹-109 Cr | Negative | |
| Mar2022 | ₹-146 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹113,590.7 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| MANKIND PHARMA | ₹109,911.0 Cr | 5.1% | 12.3% | 8.8% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.4% |
7.9% |
-6.2% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses